Nektar Therapeutics Cash Flow Statement

Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -103.04M-40.20M-136.90M-175.15M-163.31M-55.90M-82.46M-156.37M-96.69M681.31M-440.67M-444.44M-525.10M-375.12M-276.06M-118.99M
Depreciation and Depletion 13.80M13.00M11.70M11.40M13.20M
Share-based Compensation 10.33M17.40M18.89M16.20M17.71M17.02M19.67M25.85M36.62M88.10M99.80M94.26M94.67M57.32M33.39M21.61M
Deferred Taxes -0.04M-0.10M2.71M-0.14M
Gains from Investment Securities 0.74M0.41M-1.36M-2.52M1.01M0.96M2.37M0.76M0.56M0.62M57.69M2.13M1.06M3.33M2.66M0.08M
Asset Writedowns and Impairment 12.58M1.68M1.58M65.76M35.33M8.33M
Non-cash Items 11.17M10.97M56.27M
Cash from Operations 39.74M-55.87M-113.74M-129.76M-38.53M-142.01M-73.08M-117.02M-80.41M718.21M-328.68M-313.29M-412.66M-304.01M-192.61M-175.71M
Depreciation, Depletion & Amortization
Amortization of Goodwill 76.50M
Amortizatization of Intangibles -14.86M-9.24M
Depreciation & Amortization (CF) 14.88M16.55M14.95M14.51M14.28M12.93M12.86M15.35M14.74M10.87M13.16M14.18M14.15M13.03M7.82M4.39M
Change in Working Capital
Change in Receivables -6.03M20.30M-20.16M0.87M-3.58M1.38M16.34M-4.27M-10.66M25.50M-6.41M-1.91M-12.40M-16.51M-4.78M3.04M
Change in Inventory -2.85M0.80M5.39M5.61M-4.82M-0.50M-1.61M-0.24M-0.38M0.66M1.28M2.63M0.51M3.40M-0.70M-0.50M
Change in Account Payables -8.05M4.27M-3.38M-0.12M6.20M-6.36M-0.41M0.52M2.07M0.97M12.97M2.38M-11.69M3.10M-2.88M2.67M
Change in Accured Expenses -4.19M1.68M3.56M5.28M9.16M-13.80M3.03M12.28M-14.93M31.49M4.35M8.64M-22.93M-19.95M-17.26M10.73M
Other Working Capital Changes 126.80M-47.02M-17.52M-9.38M-12.40M-4.66M-17.53M-17.61M-28.27M31.65M-16.57M-5.52M2.59M-6.91M-3.58M4.19M
Investing Activities
Capital Expenditures 16.39M31.46M9.72M10.58M4.09M9.98M11.20M6.39M9.68M14.24M26.29M7.26M14.99M5.68M0.86M1.47M
Sales of Property, Plant and Equipment 2.63M13.20M1.25M
Change in Acquisitions & Divestments 310.71M475.81M383.05M307.89M319.18M248.00M226.92M253.68M347.74M890.96M1614.04M1449.30M1166.95M826.23M650.88M340.36M
Cash from Investing Activities -149.03M16.71M-111.95M113.02M49.91M-37.57M-14.34M-82.40M-28.81M-1379.94M206.89M496.21M202.78M365.83M139.56M142.57M
Financing Activities
Other financing activities 4.53M119.59M-3.00M-7.00M146.25M3.00M0.75M
Cash from Financing Activities 3.54M7.54M222.34M26.80M2.22M152.98M130.78M203.62M54.39M851.97M23.36M-80.35M36.24M1.51M0.03M42.12M
Additional items
Exchange Rate Effect -0.23M-0.22M0.92M0.06M0.03M-0.11M-0.16M-0.12M-0.05M-0.10M-0.10M0.02M-0.09M-0.33M0.06M-0.00M
Change in Cash -105.99M-31.84M-2.44M10.12M13.63M-26.70M43.20M4.07M-54.88M190.14M-98.54M102.59M-173.74M63.01M-52.95M8.97M
Free Cash Flow 23.35M-87.33M-123.46M-140.34M-42.62M-151.98M-84.28M-123.42M-90.09M703.98M-354.97M-320.55M-427.65M-309.68M-193.47M-177.18M
Net Cash Flow -105.76M-31.62M-3.36M10.06M13.60M-26.59M43.36M4.19M-54.83M190.24M-98.44M102.57M-173.65M63.34M-53.01M8.98M